Abstract
Febrile neutropenia in patients with hematological malignancies is a condition characterized by a high risk of sepsis and septic shock, resulting in the need for aggressive treatment for all patients. However, most patients with febrile neutropenia evolve without complications. Several inflammatory markers and clinical variables have been evaluated as biomarkers for risk stratification o…